|
Volumn 35, Issue 2, 2007, Pages 86-88
|
Non-alcoholic fatty liver disease
|
Author keywords
abnormal liver biochemistry; cirrhosis; metabolic syndrome; non alcoholic fatty liver disease
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ALANINE AMINOTRANSFERASE;
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
ASPARTATE AMINOTRANSFERASE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INSULIN;
LIPID;
METFORMIN;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;
PIOGLITAZONE;
ROSIGLITAZONE;
ALCOHOL LIVER DISEASE;
ASCITES;
BARIATRIC SURGERY;
BLOOD ANALYSIS;
BODY MASS;
CARDIOVASCULAR DISEASE;
CLINICAL FEATURE;
CLINICAL TRIAL;
DIFFERENTIAL DIAGNOSIS;
DISEASE ASSOCIATION;
DISEASE COURSE;
ECHOGRAPHY;
ESOPHAGUS VARICES BLEEDING;
FATTY LIVER;
HISTOPATHOLOGY;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
INSULIN RESISTANCE;
LIVER BIOPSY;
LIVER CIRRHOSIS;
LIVER FIBROSIS;
METABOLIC SYNDROME X;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONALCOHOLIC FATTY LIVER;
OBESITY;
PREVALENCE;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
RISK FACTOR;
SYMPTOM;
WEIGHT REDUCTION;
|
EID: 33846369176
PISSN: 13573039
EISSN: None
Source Type: Journal
DOI: 10.1016/j.mpmed.2006.11.010 Document Type: Review |
Times cited : (14)
|
References (5)
|